As of 3:59pm ET
| -0.09 / -0.08%|
The 4 analysts offering 12-month price forecasts for Bio-Techne Corp have a median target of 117.00, with a high estimate of 140.00 and a low estimate of 108.00. The median estimate represents a +8.08% increase from the last price of 108.25.
The current consensus among 5 polled investment analysts is to Buy stock in Bio-Techne Corp. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.